UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 濾胞性リンパ腫における同種造血細胞移植allogeneic hematopoietic cell transplantation in follicular lymphoma [show details]
…chemoimmunotherapy alone or allogeneic HCT . We consider nonmyeloablative or reduced intensity allogeneic HCT for eligible patients who relapse after autologous HCT. The use of allogeneic HCT, however, is limited …
2. 多発性骨髄腫：同種造血細胞移植multiple myeloma use of allogeneic hematopoietic cell transplantation [show details]
…alone or with autologous HCT is improving. As such, the role of allogeneic HCT in the treatment of MM is not clear. The use of allogeneic HCT in the management of patients with MM will be reviewed here …
3. 同種造血細胞移植後の肺合併症pulmonary complications after allogeneic hematopoietic cell transplantation [show details]
…complications of allogeneic HCT also occur with autologous HCT, but there are some important differences. Prevention of graft rejection and graft-versus-host disease (GVHD) in allogeneic HCT necessitates …
4. 同種造血細胞移植の適応判定determining eligibility for allogeneic hematopoietic cell transplantation [show details]
…associated with allogeneic HCT must be compared with those of other treatment approaches. The role of allogeneic HCT in specific diseases is discussed in more detail separately. In general, allogeneic HCT may …
5. 同種造血幹細胞移植後に血液癌の再発を予防および治療するための免疫療法immunotherapy for the prevention and treatment of relapse following allogeneic hematopoietic cell transplantation [show details]
…that relapsed after allogeneic HCT . Multiple myeloma – Bortezomib and lenalidomide have been administered together with DLI in patients with residual multiple myeloma after allogeneic HCT and appeared to …

Japanese Journal

IMMUNOREGULATORY ACTIVITY IN HUMAN DECIDUA :

KITANO Yoichiro,FUJISAKI Shunichi,NAKAMURA Naoki,OKAMURA Hitoshi
日本産科婦人科學會雜誌 42(7), 739-746, 1990
… ヒトにおける妊娠は, 免疫学的にはallograftが同種異系の個体に生着すると言うparadoxicalな現象と考えられる. …
NAID 110002105734

ハツカネズミの移植癌に対する同種同系,同種異系のゼラチンの抗移植性の免疫

榎木義祐
医学と生物学 100(2), p111-112, 1980-02
NAID 40000109638

マクロファージ由来可溶性因子の抗体産生における役割

高田優
アレルギー 26(9), 631-639,672, 1977
… ージの培養上清にはこのような活性はなかった.チオグリコレート刺激のマクロファージに抗原を加えて得た上清には非特異因子の活性とともに, 抗原に対して特異性を持つ因子の活性がみられた.非特異因子は非免疫リンパ球のみならず, 免疫リンパ球にも有効に作用し, その活性は組織適合性にかかわりなく同種異系のリンパ球にも有効であった.抗原特異因子の活性は, 同種系の免疫リンパ球に対してはみられなかった. …
NAID 110002410691